Cellogen Therapeutics - Total Funding, Funding Over Time, Funding By Rounds and More
Founded in 2021, Cellogen Therapeutics operates in Health Tech offering advanced cellular engineering methods and gene therapy-based approaches to find curative treatments for various hematological ma...
Funding stage:
Undisclosed
Last funding:
17/05/2026
Total funding:
$3.81 Mn+
Revenue:
Investors
Cellogen Therapeutics: Funding Highlights
Funding highlights of Cellogen Therapeutics and a snapshot of its key metrics.
Total Funding$3.81 Mn+
Current StageUndisclosed
Total Round(s)2
Funding Rounds
FAQs on Funding of Cellogen Therapeutics
Health Tech Funded Cellogen Therapeutics has raised a total funding of $3.81 million as of 18 May 2026 across 2 rounds. Find the details around funding rounds, participating investors, and other insights of Cellogen Therapeutics here...
Cellogen Therapeutics has raised a total of $3.81 million across 2 funding rounds and the last round was raised on 18 May 2026.
Cellogen Therapeutics's key investors include Kotak Alternate Asset Managers and Natco Pharma.
Cellogen Therapeutics's latest funding round was $2.00 million in Undisclosed, raised on 18 May 2026.
Cellogen Therapeutics is at the Undisclosed stage. Its most recent round was raised on 18 May 2026.
Cellogen Therapeutics's last known valuation was $32.79 million as of 17 January 2024.
Disclaimer
Inc42 Datalabs consolidates intelligence from public records, statutory filings, proprietary research, and vetted third‑party datasets. All information is provided as is—please run your own checks before acting on it. Inc42 Datalabs bears no responsibility for decisions or outcomes based on this data.
Quick Links